175 related articles for article (PubMed ID: 23076139)
1. MMP-9 and uPAR regulated glioma cell migration.
Veeravalli KK; Rao JS
Cell Adh Migr; 2012; 6(6):509-12. PubMed ID: 23076139
[TBL] [Abstract][Full Text] [Related]
2. MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.
Veeravalli KK; Chetty C; Ponnala S; Gondi CS; Lakka SS; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
PLoS One; 2010 Jul; 5(7):e11583. PubMed ID: 20657647
[TBL] [Abstract][Full Text] [Related]
3. Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration.
Zhuang T; Chelluboina B; Ponnala S; Velpula KK; Rehman AA; Chetty C; Zakharian E; Rao JS; Veeravalli KK
BMC Cancer; 2013 Dec; 13():590. PubMed ID: 24325546
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of cathepsin B and uPAR inhibits CD151 and α3β1 integrin-mediated cell adhesion and invasion in glioma.
Rao Malla R; Gopinath S; Alapati K; Gorantla B; Gondi CS; Rao JS
Mol Carcinog; 2013 Oct; 52(10):777-90. PubMed ID: 22495828
[TBL] [Abstract][Full Text] [Related]
5. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
[TBL] [Abstract][Full Text] [Related]
6. uPAR and cathepsin B knockdown inhibits radiation-induced PKC integrated integrin signaling to the cytoskeleton of glioma-initiating cells.
Alapati K; Gopinath S; Malla RR; Dasari VR; Rao JS
Int J Oncol; 2012 Aug; 41(2):599-610. PubMed ID: 22641287
[TBL] [Abstract][Full Text] [Related]
7. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
[TBL] [Abstract][Full Text] [Related]
8. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
Kunigal S; Lakka SS; Gondi CS; Estes N; Rao JS
Int J Cancer; 2007 Nov; 121(10):2307-16. PubMed ID: 17657740
[TBL] [Abstract][Full Text] [Related]
9. siRNA-mediated downregulation of MMP-9 and uPAR in combination with radiation induces G2/M cell-cycle arrest in Medulloblastoma.
Nagaraju GP; Nalla AK; Gupta R; Mohanam S; Gujrati M; Dinh DH; Rao JS
Mol Cancer Res; 2011 Jan; 9(1):51-66. PubMed ID: 21148633
[TBL] [Abstract][Full Text] [Related]
10. Urokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cells.
Chetty C; Lakka SS; Bhoopathi P; Gondi CS; Veeravalli KK; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
Mol Cancer Ther; 2010 Sep; 9(9):2605-17. PubMed ID: 20716639
[TBL] [Abstract][Full Text] [Related]
11. Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells.
Raghu H; Sodadasu PK; Malla RR; Gondi CS; Estes N; Rao JS
BMC Cancer; 2010 Nov; 10():647. PubMed ID: 21106094
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes.
Adachi Y; Lakka SS; Chandrasekar N; Yanamandra N; Gondi CS; Mohanam S; Dinh DH; Olivero WC; Gujrati M; Tamiya T; Ohmoto T; Kouraklis G; Aggarwal B; Rao JS
J Biol Chem; 2001 Dec; 276(50):47171-7. PubMed ID: 11572856
[TBL] [Abstract][Full Text] [Related]
13. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
[TBL] [Abstract][Full Text] [Related]
14. Integrin α9β1-mediated cell migration in glioblastoma via SSAT and Kir4.2 potassium channel pathway.
Veeravalli KK; Ponnala S; Chetty C; Tsung AJ; Gujrati M; Rao JS
Cell Signal; 2012 Jan; 24(1):272-81. PubMed ID: 21946432
[TBL] [Abstract][Full Text] [Related]
15. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.
Nalla AK; Gorantla B; Gondi CS; Lakka SS; Rao JS
Cancer Gene Ther; 2010 Sep; 17(9):599-613. PubMed ID: 20448670
[TBL] [Abstract][Full Text] [Related]
16. uPAR and cathepsin B inhibition enhanced radiation-induced apoptosis in gliomainitiating cells.
Malla RR; Gopinath S; Alapati K; Gorantla B; Gondi CS; Rao JS
Neuro Oncol; 2012 Jun; 14(6):745-60. PubMed ID: 22573309
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induced by knockdown of uPAR and MMP-9 is mediated by inactivation of EGFR/STAT3 signaling in medulloblastoma.
Kotipatruni RR; Nalla AK; Asuthkar S; Gondi CS; Dinh DH; Rao JS
PLoS One; 2012; 7(9):e44798. PubMed ID: 22984561
[TBL] [Abstract][Full Text] [Related]
18. Co-depletion of cathepsin B and uPAR induces G0/G1 arrest in glioma via FOXO3a mediated p27 upregulation.
Gopinath S; Malla RR; Gondi CS; Alapati K; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
PLoS One; 2010 Jul; 5(7):e11668. PubMed ID: 20661471
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of p27 upregulation induced by downregulation of cathepsin B and uPAR in glioma.
Gopinath S; Alapati K; Malla RR; Gondi CS; Mohanam S; Dinh DH; Rao JS
Mol Oncol; 2011 Oct; 5(5):426-37. PubMed ID: 21840777
[TBL] [Abstract][Full Text] [Related]
20. Heat shock proteins HSP70 and MRJ cooperatively regulate cell adhesion and migration through urokinase receptor.
Lin Y; Peng N; Zhuang H; Zhang D; Wang Y; Hua ZC
BMC Cancer; 2014 Aug; 14():639. PubMed ID: 25175595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
